| 881.51 0.65 (0.07%) | 09-11 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1044.7 | 1-year : | 1086.18 |
| Resists | First : | 894.43 | Second : | 929.95 |
| Pivot price | 893.41  |
|||
| Supports | First : | 836.99 | Second : | 696.37 |
| MAs | MA(5) : | 890.23 |
MA(20) : | 884.36 |
| MA(100) : | 814.27 |
MA(250) : | 830.71 |
|
| MACD | MACD : | 10.8 |
Signal : | 14.3 |
| %K %D | K(14,3) : | 51.3 |
D(3) : | 56.3 |
| RSI | RSI(14): 50.7 |
|||
| 52-week | High : | 996.83 | Low : | 684.98 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MCK ] has closed above bottom band by 32.6%. Bollinger Bands are 18.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 894.7 - 901 | 901 - 905.9 |
| Low: | 862.51 - 869.2 | 869.2 - 874.4 |
| Close: | 872.84 - 883.12 | 883.12 - 891.09 |
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Thu, 10 Sep 2026
McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights - finance.yahoo.com
Thu, 10 Sep 2026
McKesson Corp (MCK) Insider Sale: SVP, Controller & CAO Rutledge Napoleon B JR Sells 111 Shares - GuruFocus
Thu, 10 Sep 2026
McKesson (MCK) Plans A $2.25b Deal, Is The Stock Fully Valued? - simplywall.st
Wed, 09 Sep 2026
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - finance.yahoo.com
Wed, 09 Sep 2026
McKesson (MCK) Stock Still Looks Reasonable Following Third Party Cyberattack - simplywall.st
Tue, 08 Sep 2026
McKesson at wells fargo healthcare conference: growth, deal push - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 117 (M) |
| Shares Float | 116 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 93.6 (%) |
| Shares Short | 2,420 (K) |
| Shares Short P.Month | 3,880 (K) |
| EPS | 37.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -36.55 |
| Profit Margin | 1.1 % |
| Operating Margin | 1.3 % |
| Return on Assets (ttm) | 4.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 7.6 % |
| Gross Profit (p.s.) | 128.05 |
| Sales Per Share | 3525 |
| EBITDA (p.s.) | 60.63 |
| Qtrly Earnings Growth | -17.7 % |
| Operating Cash Flow | 6,850 (M) |
| Levered Free Cash Flow | 6,800 (M) |
| PE Ratio | 23.62 |
| PEG Ratio | 1.7 |
| Price to Book value | -24.12 |
| Price to Sales | 0.25 |
| Price to Cash Flow | 15 |
| Dividend | 0.93 |
| Forward Dividend | 0 |
| Dividend Yield | 0.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|